| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.2 | 0.004 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.15 | 0.005 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.005 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.006 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.13 | 0.007 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.098 | 0.007 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.007 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.2 | 0.008 |